Drug Recall


HPS Pharmacies wish to advise that Apotex Australia Pty Ltd, in consultation with the Therapeutic Goods Administration (TGA), have given notice of a drug recall of:

APO-Cabergoline Tablets
Cabergoline 500µg
ARTG 218126

The only affected batch is MK0903 with an expiry date of February 2017.

This recall has been initiated due to a packaging issue that may increase degradation of the product in moist conditions over time.

Please inspect your stocks and quarantine all products from the batch stated above for return to your supplier for a refund.

Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies, or Apotex on 1800 276 839.

Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates